MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
CareDx, Inc DPO Ratio 2011-2025 | CDNA
Annual DPO Ratio CareDx, Inc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 44.2 | 52.1 | 57.9 | 53 | 58.4 | 48.2 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.4 | 44.2 | 52.3 |
Quarterly DPO Ratio CareDx, Inc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 58.6 | 55.8 | - | 43.7 | 43.6 | 47.9 | - | 48.4 | 59.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 59.6 | 43.6 | 51.1 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DarioHealth Corp.
DRIO
|
43.9 | $ 11.99 | 0.84 % | $ 340 M |  Israel |
 |
DexCom
DXCM
|
70.4 | $ 66.58 | -0.56 % | $ 25.7 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 16.59 | 5.33 % | $ 178 M |  China |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
139 | $ 101.55 | 0.04 % | $ 18.8 B | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
104 | $ 1.57 | -3.24 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
IQVIA Holdings
IQV
|
126 | $ 222.02 | -0.11 % | $ 40.3 B | USA |
 |
Castle Biosciences
CSTL
|
52 | $ 38.66 | 0.08 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
66.4 | $ 224.85 | -0.65 % | $ 164 B | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 26.66 | -1.77 % | $ 806 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 407.64 | 1.0 % | $ 29.9 B |  Schweiz |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Myriad Genetics
MYGN
|
42 | $ 6.95 | -3.68 % | $ 630 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
20.7 | $ 11.82 | -0.25 % | $ 1.5 B | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 6.77 | -1.31 % | $ 1.47 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.29 K | $ 3.51 | -1.96 % | $ 112 K | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 0.31 | -9.26 % | $ 9.1 M | USA |
 |
Pacific Biosciences of California
PACB
|
33.5 | $ 2.09 | -1.65 % | $ 530 M | USA |
 |
Quidel Corporation
QDEL
|
101 | $ 28.63 | -0.59 % | $ 1.21 B | USA |
 |
Guardant Health
GH
|
83.6 | $ 102.49 | 0.41 % | $ 12.6 B | USA |
 |
Precipio
PRPO
|
53 | $ 24.0 | -3.88 % | $ 31.1 M | USA |
 |
QIAGEN N.V.
QGEN
|
50 | $ 45.24 | 0.04 % | $ 10.1 B |  Niderland |
 |
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
46.2 | $ 16.74 | -0.53 % | $ 4.73 B | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
130 | $ 51.69 | -0.6 % | $ 2.08 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
56.3 | $ 133.64 | -0.91 % | $ 21.2 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 195.46 | 1.26 % | $ 10 B | USA |
 |
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 566.18 | -0.96 % | $ 216 B | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 1.14 | 6.54 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 30.51 | -1.36 % | $ 1.82 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 184.09 | 0.84 % | $ 20.4 B | USA |